Shopping Cart
Remove All
Your shopping cart is currently empty
CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor that exhibits lower cytotoxicity compared to BIX-01294 [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor that exhibits lower cytotoxicity compared to BIX-01294 [1]. |
| In vitro | CSV0C018875, at concentrations ranging from 2.5 to 20 μM over a 48-hour period, reduces H3K9me2 modification levels in histones [1]. Through Western Blot Analysis [1] conducted on HEK293 cells, with doses of 2.5 μM, 10 μM, and 20 μM, it was observed that CSV0C018875 progressively inhibits G9a enzymatic activity in a dose-dependent manner. |
| Molecular Weight | 312.79 |
| Formula | C18H17ClN2O |
| Cas No. | 442150-41-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.